CGGRGD TFA (1260223-44-6 free base)
CAS No. ——
CGGRGD TFA (1260223-44-6 free base)( —— )
Catalog No. M30367 CAS No. ——
CGGRGD TFA is synthesized via solid-phase peptide synthesis technique and the surface of PCL fibers is aminolysised by amino 2-cyanobenzothiazole followed by the addition of 2-cyanobenzothiazole (CBT).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameCGGRGD TFA (1260223-44-6 free base)
-
NoteResearch use only, not for human use.
-
Brief DescriptionCGGRGD TFA is synthesized via solid-phase peptide synthesis technique and the surface of PCL fibers is aminolysised by amino 2-cyanobenzothiazole followed by the addition of 2-cyanobenzothiazole (CBT).
-
DescriptionCGGRGD TFA is synthesized via solid-phase peptide synthesis technique and the surface of PCL fibers is aminolysised by amino 2-cyanobenzothiazole followed by the addition of 2-cyanobenzothiazole (CBT).(In Vitro):CGGRGD TFA is a characteristic sequence of fifibronectin that binds to the receptors on cell surface. (PCL) is a popular materials for tissue engineering due to its optimal biocompatibility, biodegradability, and thermoplastic characteristics.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight677.61
-
Molecular FormulaC21H34F3N9O11S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Cys}{Gly}{Gly}{Arg}{Gly}{Asp}
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Wenting Zhen, et al.Functionalization of PCL fibrous membrane with RGD peptide
molnova catalog
related products
-
o-Toluic acid
o-Toluic acid also 2-methylbenzoic acid is an aromatic carboxylic acid. It is a human xenobiotic metabolite.
-
Isonemerosin
Isonemerosin is a natural product for research related to life sciences.
-
mTOR inhibitor 9a
mTOR inhibitor 9a inhibited the growth of human LNCap cells with an ic50 of 80 nm. 1-methyl-3 -{4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)thieno[3,2-d]pyrimidin-2-yl]phenyl}urea may have antitumor activity.
Cart
sales@molnova.com